Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Piperaquine
77%
Dihydroartemisinin
72%
Oseltamivir
71%
Artemisinin
61%
Elimination
56%
Mefloquine
55%
Ivermectin
53%
Combination Therapy
40%
Relenza
35%
4 Acetamido 5 Amino 3 (1 Ethylpropoxy) 1 Cyclohexene 1 Carboxylic Acid
32%
Diseases
29%
Pharmacometrics
28%
Tolerability
27%
SARS Coronavirus
26%
Immunogenicity
23%
Antivirus Agent
23%
Artesunate Plus Pyronaridine
22%
Malaria Vaccine
21%
Viral Clearance
21%
Antimalarial Activity
20%
Pharmacodynamics
20%
Influenza
20%
Randomized Clinical Trial
19%
Molnupiravir
17%
Splenomegaly
17%
Spontaneous Abortion
17%
Dengue
17%
Tafenoquine
17%
Indicator
17%
Endoperoxide
17%
Artefenomel
17%
Tenofovir
17%
Coronavirinae
17%
Clinical Feature
17%
Blindness
17%
Remdesivir
17%
Antimalarial Agent
17%
Antiviral Activity
12%
Glucose 6 Phosphate Dehydrogenase Deficiency
11%
Nucleoside
11%
Vaccination Policy
11%
Infection
11%
Amodiaquine
10%
Drug Administration
10%
Clinical Trial
10%
Quinine
10%
Plasmodium falciparum
10%
Scabies
8%
Plasmodium Ovale Malaria
8%
Medicine and Dentistry
Child
71%
Therapeutic Procedure
65%
Malaria
56%
Antivirus Agent
53%
Patient
45%
COVID-19
39%
Inpatient
35%
Pregnancy
35%
Patient-Data
35%
Meta-Analysis
35%
Viral Clearance
34%
Drug
27%
Woman
22%
Malaria Falciparum
21%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Parasite (Microbiology)
20%
Student
20%
Nirmatrelvir
19%
Contraindication
17%
Systematic Review
17%
Tuberculosis
17%
Scrub Typhus
17%
Nonnucleoside Reverse Transcriptase Inhibitor
17%
Splenomegaly
17%
Myocarditis
17%
Tenofovir
17%
Mefloquine
17%
Antiretroviral Therapy
17%
Hepatitis B Virus
17%
Absence
17%
Genomic Epidemiology
17%
Intervention Study
17%
Observational Study
17%
Health
17%
Evaluation Study
17%
Consent
17%
Pharmacodynamics
17%
Anopheles
17%
Disease
17%
Combination Therapy
14%
Newborn Care
11%
Culture
11%
Life
10%
Dihydroartemisinin
9%
Complication
8%
Virus DNA
8%
Tenofovir Disoproxil
8%
Antimalarial Agent
8%
Quinine
7%
Adult
7%